Chemotherapeutic regimen influences the results of chemotherapy plus immunotherapy

Immunotherapy. 2019 Oct;11(15):1259-1261. doi: 10.2217/imt-2019-0149. Epub 2019 Sep 18.

Author

Affiliation

¹ Department of Immunotherapy, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No. 127, Dongming Road, Jinshui District, Zhengzhou City 450008, China.

PMID: 31530053
DOI: 10.2217/imt-2019-0149

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Immunologic Factors / therapeutic use
Immunotherapy / methods*
Neoplasms / drug therapy*

Substances

Immunologic Factors